FDA Pushes for Streamlined Human Trials to Study Cancer Meds

August 15, 2018

Drugmakers could opt to use one clinical trial to study certain cancer drugs in humans rather than the three separate trials traditionally needed, thanks to the Food and Drug Administration’s (FDA) latest push to streamline drug approvals.

Related Stories